Cite
MLA Citation
A. McDonald et al.. “P825: FACTOR D INHIBITION WITH ORAL BCX9930 MONOTHERAPY LEADS TO SUSTAINED CONTROL OF HEMOLYSIS AND SYMPTOMS OVER 48 WEEKS IN SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA NAÏVE TO C5 INHIBITORS.” HemaSphere, vol. 6, n.d., pp. 719–720. http://access.bl.uk/ark:/81055/vdc_100159757515.0x000005